Donn J Colby
Overview
Explore the profile of Donn J Colby including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
978
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kunz A, Moodley A, Colby D, Soltis M, Robb-McGrath W, Fairchok A, et al.
BMC Public Health
. 2022 Apr;
22(1):640.
PMID: 35366848
Background: Over the past 10 years, incidence of sexually transmitted infections (STIs) has increased to record numbers in the United States, with the most significant increases observed among adolescents and...
12.
Kroon E, Chottanapund S, Buranapraditkun S, Sacdalan C, Colby D, Chomchey N, et al.
J Infect Dis
. 2022 Mar;
225(12):2167-2175.
PMID: 35275599
Starting antiretroviral therapy (ART) in Fiebig 1 acute HIV infection limits the size of viral reservoirs in lymphoid tissues, but does not impact time to virus rebound during a treatment...
13.
van Griensven F, Phanuphak N, Manopaiboon C, Dunne E, Colby D, Chaiphosri P, et al.
PLoS One
. 2022 Jan;
17(1):e0262694.
PMID: 35061803
To reach its goal of ending AIDS by 2030, Thailand has adopted antiretroviral treatment as prevention and HIV pre-exposure prophylaxis for men who have sex with men (MSM) and transgender...
14.
Peay H, Rennie S, Cadigan R, Gwaltney A, Jupimai T, Phanuphak N, et al.
AIDS Behav
. 2022 Jan;
26(5):1504-1516.
PMID: 34997386
HIV remission trials often require temporary stopping of antiretroviral therapy (ART)-an approach called analytic treatment interruption (ATI). Trial designs resulting in viremia raise risks for participants and sexual partners. We...
15.
Muccini C, Pinyakorn S, Sirivichayakul S, Kroon E, Sacdalan C, Crowell T, et al.
J Acquir Immune Defic Syndr
. 2021 Jul;
87(5):1173-1177.
PMID: 34229330
Background: The greater availability of different antiretroviral therapy regimens in developing countries may influence the emergence of transmitted drug resistance (TDR). People with acute HIV infection (AHI) represent the best...
16.
Goh O, Kroon E, Sacdalan C, Chan P, Crowell T, Kanaprach R, et al.
AIDS Care
. 2021 Jun;
34(8):949-956.
PMID: 34191663
The health-related quality of life (HRQoL) among persons living with HIV (PLWHA) who initiate ART during acute HIV infection (AHI) is not well studied. Participants in the SEARCH010/RV254 cohort initiated...
17.
Muccini C, Crowell T, Pinyakorn S, Kroon E, Sacdalan C, Ananworanich J, et al.
J Acquir Immune Defic Syndr
. 2021 Jan;
86(2):219-223.
PMID: 33433124
Background: Syphilis has been increasing in the past years, especially among men who have sex with men (MSM). The aim of the study was to assess syphilis prevalence and incidence...
18.
Kroon E, Ananworanich J, Pagliuzza A, Rhodes A, Phanuphak N, Trautmann L, et al.
J Virus Erad
. 2020 Nov;
6(3):100004.
PMID: 33251022
Objective And Design: A randomized, open-label pilot study in individuals treated with antiretroviral therapy (ART) since acute HIV infection (AHI) with a regimen including a histone deacetylase inhibitor to induce...
19.
Cai C, Pinyakorn S, Kroon E, de Souza M, Colby D, Pankam T, et al.
Open Forum Infect Dis
. 2020 Oct;
7(9):ofaa383.
PMID: 33005700
Persistent viral activity may cause enduring seropositivity and inflammation in treated people with HIV (PWH). We compared inflammatory biomarkers between early treated PWH who remained seronegative or seroconverted and found...
20.
Handoko R, Colby D, Kroon E, Sacdalan C, de Souza M, Pinyakorn S, et al.
J Int AIDS Soc
. 2020 Sep;
23(9):e25585.
PMID: 32949118
Introduction: Up to 30% of individuals treated with antiretroviral therapy (ART) during chronic HIV fail to recover CD4 counts to >500 cells/mm despite plasma viral suppression. We investigated the frequency...